Fosamax

Fosamax is typically prescribed for the purpose of treating or preventing osteopenia and osteoporosis in both men and women. It is manufactured by Merck and Company and was approved by the FDA in 1995.

The use of Fosamax has been linked to a serious condition called osteonecrosis, a disease resulting from the loss of blood supply to the bones causing the bone tissue to die and the bone to collapse. One of the more common forms of osteonecrosis associated with taking Fosamax is called osteonecrosis of the jaw (ONJ), a condition that causes infection and rotting of the jaw bones. Warning signs of this condition include, but are not limited to jaw pain, swelling and infection in jaw, tooth loss or loosening, and exposed bone.

It is ironic that this drug is prescribed to prevent or reverse bone loss and has in reality been causing bone loss. The FDA issued warnings concerning the use of this drug in September, 2004.

If you or a loved one has suffered from a form of osteonecrosis or ONJ as a result of taking Fosamax, you may be entitled to compensation. Call us at (478) 745-9002 for a free consultation.